Osaic Holdings
AVNS

Osaic Holdings’s Avanos Medical AVNS Stock Holding History

Osaic Holdings’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150K Buy
6,011
+1,560
+35% +$36.5K ﹤0.01% 4651
2026
Q1 		$62.4K Sell
4,451
-404
-8% -$5.44K ﹤0.01% 5041
2025
Q4 		$54.5K Sell
4,855
-960
-17% -$11K ﹤0.01% 5168
2025
Q3 		$69K Buy
5,815
+3,223
+124% +$37.7K ﹤0.01% 5088
2025
Q2 		$31.7K Sell
2,592
-112
-4% -$1.41K ﹤0.01% 5366
2025
Q1 		$38.7K Sell
2,704
-279
-9% -$4.36K ﹤0.01% 4898
2024
Q4 		$47.5K Buy
2,983
+178
+6% +$3.52K ﹤0.01% 4745
2024
Q3 		$67.4K Buy
2,805
+294
+12% +$6.72K ﹤0.01% 4527
2024
Q2 		$50K Sell
2,511
-1,243
-33% -$24.2K ﹤0.01% 4675
2024
Q1 		$74.7K Sell
3,754
-7,449
-66% -$144K ﹤0.01% 4455
2023
Q4 		$251K Sell
11,203
-5,662
-34% -$117K ﹤0.01% 3733
2023
Q3 		$341K Buy
16,865
+5,472
+48% +$124K ﹤0.01% 3577
2023
Q2 		$291K Buy
11,393
+870
+8% +$22.9K ﹤0.01% 3601
2023
Q1 		$313K Buy
10,523
+1,539
+17% +$44.7K ﹤0.01% 3513
2022
Q4 		$242K Buy
8,984
+1,999
+29% +$48.9K ﹤0.01% 3685
2022
Q3 		$152K Sell
6,985
-1,018
-13% -$26.6K ﹤0.01% 4010
2022
Q2 		$218K Sell
8,003
-18,022
-69% -$518K ﹤0.01% 3705
2022
Q1 		$859K Buy
26,025
+18,011
+225% +$580K ﹤0.01% 2720
2021
Q4 		$278K Buy
8,014
+1,523
+23% +$49.2K ﹤0.01% 3644
2021
Q3 		$203K Buy
6,491
+2,386
+58% +$81K ﹤0.01% 3883
2021
Q2 		$150K Sell
4,105
-89
-2% -$3.68K ﹤0.01% 4120
2021
Q1 		$183K Sell
4,194
-270
-6% -$12.7K ﹤0.01% 3820
2020
Q4 		$203K Sell
4,464
-350
-7% -$14.6K ﹤0.01% 3474
2020
Q3 		$160K Sell
4,814
-1,389
-22% -$44.4K ﹤0.01% 3443
2020
Q2 		$182K Sell
6,203
-79,347
-93% -$2.3M ﹤0.01% 3213
2020
Q1 		$135K Buy
+85,550
New +$2.55M ﹤0.01% 3226

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Osaic Holdings's AVNS Position: Q2 2026 in Review

Osaic Holdings increased its Avanos Medical (AVNS) stake by 35% in Q2 2026, buying an estimated $36.5K and bringing the position to 6,011 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #4651.

Osaic Holdings first reported a position in AVNS in Q1 2020 and has held it in 26 quarters since. The position peaked at $859K in Q1 2022. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Osaic Holdings held 6,011 shares of Avanos Medical worth $150K as of Q2 2026.
  • Osaic Holdings bought 1,560 Avanos Medical shares in Q2 2026, an estimated $36.5K.
  • Avanos Medical made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4651 holding.
  • Osaic Holdings first reported a position in Avanos Medical in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Avanos Medical position peaked at $859K in Q1 2022.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.